News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,728 Results
Type
Article (61295)
Company Profile (72)
Press Release (584361)
Multimedia
Podcasts (61)
Webinars (13)
Section
Business (173680)
Career Advice (2730)
Deals (32431)
Drug Delivery (97)
Drug Development (76844)
Employer Resources (150)
FDA (14936)
Job Trends (13886)
News (304845)
Policy (28947)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (90)
Alliances (43142)
ALS (94)
Alzheimer's disease (1325)
Antibody-drug conjugate (ADC) (116)
Approvals (14946)
Artificial intelligence (275)
Autoimmune disease (24)
Automation (16)
Bankruptcy (290)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (102)
Biotechnology (54)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (285)
Cancer (2243)
Cardiovascular disease (170)
Career advice (2313)
Career pathing (33)
CAR-T (159)
Cell therapy (442)
Cervical cancer (21)
Clinical research (62587)
Collaboration (811)
Company closure (2)
Compensation (346)
Complete response letters (20)
COVID-19 (2573)
CRISPR (45)
C-suite (271)
Cystic fibrosis (103)
Data (2271)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (256)
Diagnostics (6161)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (102)
Drug shortages (23)
Duchenne muscular dystrophy (89)
Earnings (60491)
Editorial (41)
Employer branding (18)
Employer resources (132)
Events (94615)
Executive appointments (779)
FDA (16303)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (768)
Gene editing (114)
Generative AI (21)
Gene therapy (312)
GLP-1 (675)
Government (4472)
Grass and pollen (6)
Guidances (154)
Healthcare (18206)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (114)
Indications (28)
Infectious disease (2710)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (98)
Interviews (527)
IPO (14823)
IRA (38)
Job creations (3414)
Job search strategy (1941)
Kidney cancer (10)
Labor market (34)
Layoffs (513)
Leadership (22)
Legal (6435)
Liver cancer (70)
Lung cancer (309)
Lymphoma (148)
Machine learning (9)
Management (53)
Manufacturing (293)
MASH (73)
Medical device (12658)
Medtech (12663)
Mergers & acquisitions (18214)
Metabolic disorders (653)
Multiple sclerosis (80)
NASH (13)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1860)
NextGen: Class of 2025 (6373)
Non-profit (4315)
Now hiring (13)
Obesity (327)
Opinion (233)
Ovarian cancer (77)
Pain (96)
Pancreatic cancer (84)
Parkinson's disease (144)
Partnered (22)
Patents (245)
Patient recruitment (115)
Peanut (50)
People (59599)
Pharmaceutical (20)
Pharmacy benefit managers (16)
Phase I (19701)
Phase II (27629)
Phase III (20155)
Pipeline (1302)
Policy (134)
Postmarket research (2469)
Preclinical (8409)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (250)
Rare diseases (369)
Real estate (5984)
Recruiting (61)
Regulatory (20145)
Reports (34)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (6)
RNA editing (3)
RSV (35)
Schizophrenia (71)
Series A (132)
Series B (89)
Service/supplier (9)
Sickle cell disease (52)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3346)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (33)
The Weekly (33)
Vaccines (675)
Venture capitalists (35)
Weight loss (204)
Women's health (31)
Worklife (19)
Date
Today (170)
Last 7 days (933)
Last 30 days (2917)
Last 365 days (30342)
2025 (11218)
2024 (32276)
2023 (36337)
2022 (46621)
2021 (51587)
2020 (50741)
2019 (44789)
2018 (34080)
2017 (30716)
2016 (30071)
2015 (35446)
2014 (28395)
2013 (24968)
2012 (26222)
2011 (26461)
2010 (24934)
Location
Africa (871)
Alabama (55)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38093)
Australia (6852)
California (5807)
Canada (1894)
China (502)
Colorado (255)
Connecticut (265)
Delaware (150)
Europe (88993)
Florida (886)
Georgia (209)
Idaho (56)
Illinois (559)
India (25)
Indiana (289)
Iowa (10)
Japan (162)
Kansas (97)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (854)
Massachusetts (4193)
Michigan (228)
Minnesota (351)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (62)
New Hampshire (61)
New Jersey (1701)
New Mexico (29)
New York (1688)
North Carolina (978)
North Dakota (9)
Northern California (2541)
Ohio (200)
Oklahoma (15)
Oregon (36)
Pennsylvania (1282)
Puerto Rico (13)
Rhode Island (31)
South America (1177)
South Carolina (19)
South Dakota (1)
Southern California (2216)
Tennessee (99)
Texas (886)
United States (22055)
Utah (180)
Virginia (147)
Washington D.C. (52)
Washington State (523)
West Virginia (3)
Wisconsin (62)
645,728 Results for "university of oslo".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
XNK Therapeutics to present at DNB Nordic Healthcare Conference in Oslo
XNK Therapeutics AB announced that Johan Liwing, CEO, will present the company at the DNB Nordic Healthcare Conference in Oslo, Norway, on December 14 at 10:15am CET.
December 4, 2023
·
1 min read
XNK Therapeutics presented two posters at the NK2023 conference in Oslo
XNK Therapeutics AB announced that two posters, regarding bladder cancer and acute myeloid leukemia respectively, was presented at the 20th Meeting of the Society for Natural Immunity in Oslo, Norway, in September.
September 27, 2023
·
4 min read
XNK Therapeutics to present two posters at the NK2023 conference in Oslo in September
XNK Therapeutics AB announced that two posters, regarding bladder cancer and acute myeloid leukemia respectively, will be presented at the 20th Meeting of the Society for Natural Immunity in Oslo, Norway, in September
August 14, 2023
·
3 min read
Business
Awakn Life Sciences Announces Location for Larger Oslo Clinic
Awakn’s Nordic expansion begins with new Awakn Clinics Oslo
November 23, 2022
·
5 min read
IRLAB to present at DNB Nordic Healthcare Conference in Oslo
IRLAB Therapeutics AB, a company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease, announced that the company will present at the DNB Nordic Healthcare Conference on Thursday, December 15, 2022, in Oslo, Norway.
December 15, 2022
·
1 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Drug Development
BerGenBio and Oslo University Hospital Announce the AXL Inhibitor Bemcentinib will be Studied in the EU Funded EU-SolidAct trial in Hospitalised COVID-19 Patients
BerGenBio ASA and Oslo University Hospital announced the execution of a collaborative agreement to study the BerGenBio AXL inhibitor bemcentinib, in hospitalised COVID-19 patients.
January 27, 2022
·
5 min read
Nykode Therapeutics uplisted to the main list of the Oslo Stock Exchange
Nykode Therapeutics ASA announced that it has been uplisted to the main list of the Oslo Stock Exchange with first day of trading today, June 16, 2022.
June 16, 2022
·
2 min read
Lytix Biopharma - Invitation to Capital Markets Day in Oslo, June 1, 2022
The CMD is a live event, open for physical attendance at Hotel Continental in Oslo, Norway, as well as a live webcast.
May 19, 2022
·
4 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
1 of 64,573
Next
